SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

SunTrust Robinson Humphrey Initiates Coverage On Momenta Pharmaceuticals with Buy Rating, Announces $29 Price Target

SunTrust Robinson Humphrey initiates coverage on Momenta Pharmaceuticals (NASDAQ:MNTA) with a Buy rating and a $29 price target.

Benzinga · -

SunTrust Robinson Humphrey initiates coverage on Momenta Pharmaceuticals (NASDAQ:MNTA) with a Buy rating and a $29 price target.